# Blue Longevity

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/blue-longevity

- Industry: Healthcare
- Headquarters: Bulgaria
- Website: www.bluelongevity.online
- Total disclosed funding: $2.3M
- Latest round: Seed (Jul 11, 2025)
- Investors on record: 2

## About

Blue Longevity provides innovative therapy programs focused on enhancing health and longevity. Their services include advanced diagnostics and personalized treatments, aiming to optimize wellness for a diverse clientele. Founded in 2024, Blue Longevity specializes in advanced healthcare solutions. In July 2025, Blue Longevity raised EUR 2 million in seed funding led by Eleven Ventures, with participation from Sofia Angels Ventures. Blue Longevity specializes in advanced healthcare solutions aimed at enhancing longevity and overall wellness. The company offers comprehensive testing that evaluates metabolic, brain, gut, genetic, and biomarker health, allowing for early detection of potential health risks. Additionally, Blue Longevity provides tailored in-house treatments, including Hyperbaric Oxygen Therapy, Cryotherapy, and Red Light Therapy, which are designed to support individual health needs. These services are overseen by qualified physicians who utilize AI-driven analysis to generate personalized longevity reports, optimizing key health systems for clients. The company is set to launch its services in key metropolitan areas, including Athens, Istanbul, and Sofia, targeting a diverse clientele interested in preventative healthcare and wellness optimization.The revenue model for Blue Longevity is structured around direct-to-consumer services, providing a range of health diagnostics and treatment protocols. Clients engage with the company through a clear service model that may include individual assessments and treatment packages. Transactions typically involve upfront payments for specific therapies or comprehensive wellness programs. Clients may choose from various personalized therapy plans that align with their health goals, establishing a recurring relationship for ongoing health monitoring and treatment adjustments. By focusing on high-value services that integrate advanced diagnostics and personalized care, Blue Longevity aims to establish strong customer loyalty and retention, contributing to the company's financial sustainability. The company plans to use the funding from July 2025 to set up new clinics, grow its medical, clinical, and non-clinical teams, finalize and scale its therapy protocol stack, enhance its diagnostic and personalization platform, and test out go-to-market experiments.

## Funding rounds

- Seed, Jul 11, 2025, $2.3M — Eleven Ventures, Sofia Angels Ventures

## Investors

- Eleven Ventures — Seed
- Sofia Angels Ventures (https://capitalatlas.ai/funds/sofia-angels-ventures) — Seed